Periodic Reporting for period 1 - Sleepwise (Non-intrusive solution for Obstructive Sleep Apnea Syndrome)
Reporting period: 2018-08-01 to 2018-12-31
The Obstructive Sleep Apnea (OSA) is a chronic disease that afflicts approximately 100 million people, however, nearly 80%of people with this condition remain undiagnosed. Sleep Apnea has serious medical consequences but it is also economically costly. In the USA alone the estimated economic cost of undiagnosed OSA is $149.6 billion. The diagnosis of OSA is typically made after a polysomnography (PSG), an expensive test that requires an overnight stay in a sleep laboratory wired to up to 15 different devices. Today the use of Home Sleep Tests are increasing due to are less intrusive and cheaper, however, they are subject to patient error in attaching the sensors, require previous training, are cumbersome and are not appropriate for children. Tarsio Medics is a technological company that has been working during more than 10 years together with the Pneumology unit of the Hospital Trias i Pujol to develop SleepWise, an innovative system for the exploration and diagnosis of OSA based on image processing. Our patented SleepWise system is non-intrusive, low cost, does not require training. It provides automatic analysis for sleep professionals, is more reliable because it can infer sleep/awake periods and is more versatile as it can also detect other nocturnal movements such as restless legs, parasomnias and epilepsy. We plan to monetize SleepWise offering a complete end-to-end service to doctors, hospitals and health insurance companies. The market potential is large: the global sleep apnea diagnostic system market is €341.7 €205.06 of them related with Home Sleep Tests. Currently we have a beta version of the SleepWise. Now we are applying to the SME Instrument Phase 1 to carry out a Feasibility Study to assess operational, technological and economic viability as well as to elaborate a Business Plan to define the business growth, sustainability, exploitation strategies and tactics to follow paving the way to a global market.
- Market Study
- IPR strategy definition
- Corporative image design and rebranding
- Hire new personnel resources and plan the needs for the next period
- define SleepWise 2.0 specifications
- analize future technical workplan and look for external partners for tasks outsourced
- organize a multicentric validation with 6 large hospitals, reference in the medic community
- organize a pilot with pharmacies
- analise legal framework and regulatory affairs to obtain CE mark and medical device
- define business model CANVAS
- risk assessment and SWOT analysys
- Coaching
- look for funding
- financial plan
- IPR strategy definition
- Corporative image design and rebranding
- Hire new personnel resources and plan the needs for the next period
- define SleepWise 2.0 specifications
- analize future technical workplan and look for external partners for tasks outsourced
- organize a multicentric validation with 6 large hospitals, reference in the medic community
- organize a pilot with pharmacies
- analise legal framework and regulatory affairs to obtain CE mark and medical device
- define business model CANVAS
- risk assessment and SWOT analysys
- Coaching
- look for funding
- financial plan
SleepWise is beyond current competitors, as non-invasive solution for OSAHS diagnose.
our technology will help the society to avoid misdiagnosis and will help the medical community to better perform the diagnosis.
The impact will be extremely large, since we plan to do a multicentric validation with more than 350 patients, and also to include a pilot with pharmacies, to better reach the final end-user.
our technology will help the society to avoid misdiagnosis and will help the medical community to better perform the diagnosis.
The impact will be extremely large, since we plan to do a multicentric validation with more than 350 patients, and also to include a pilot with pharmacies, to better reach the final end-user.